3-(3-Bromophenyl)-1H-pyrazole-4-carbaldehyde, 250mg

3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-[(1-OXOBUTOXY)METHYL] ESTER, 97%, 5g

2-Chloro-3-bromo-5-nitrotoluene, 95+%, 1g

Tétraborate de potassium tétrahydraté, min 99,5 %, cristallisé, 500 g, emballage plastique.

1-Isocyanato-4-(trifluoromethyl)benzene, 98.0%, 5g

ETHYL 1-OXO-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLATE, 95.0%, 5g

2-Chloro-4,6-di-p-tolyl-1,3,5-triazine, 95.0%, 250mg

(R)-3-CYCLOHEXYLMORPHOLINE, 95%, 250mg

[2,3'-Bipyridin]-6'(1'H)-one, 95.0%, 25g

Fmoc-Oic-OH, 95%, 25g

4-(2-Chloroethyl)-1,3,2-dioxathiolane 2,2-dioxide, 98%, 1g

4-(TERT-BUTYLDIMETHYLSILYLOXY)-2,6-DIFLUOROPHENYLBORONIC ACID, 97.0%, 5g

(S)-(1-Boc-Pyrrolidin-3-yl)-acetic acid, 97.0%, 5g